Source: https://kinderrheumatologie.de/publikationen
Timestamp: 2019-04-24 13:56:14+00:00

Document:
Doerte Huscher1*, David Pittrow2*, Oliver Distler3, Christopher P Denton4, Ivan Foeldvari5, Marc Humbert6, Marco Matucci-Cerinic7, Otylia Kowal-Bielecka8, Jerome Avouac9, Frank Behrens10, Peter Nash11, Christian F. Opitz12, Lewis J Rubin13, James R. Seibold14 and Daniel E. Furst15 for the other coauthors of the EPOSS-OMERACT group† Interactions between rheumatologistst and cario-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis. Clinical and Experimental Rheumatology 2010, 28: 2 Suppl 58:S47-52. Impact factor- 2,4.
Avouac J, Walker U, Tyndall A, Kahan A, Matucci-Cerinic M, Allanore Y; EUSTAR, Miniati I, Muller A, Iannone F, Distler O, Becvar R, Sierakowsky S, Kowal-Bielecka O, Coelho P, Cabane J, Cutolo M, Shoenfeld Y, Valentini G, Rovensky J, Riemekasten G, Vlachoyiannopoulos P, Caporali R, Jiri S, Inanc M, Zimmermann Gorska I, Carreira P, Novak S, Czirjak L, Oliveira Ramos F, Jendro M, Chizzolini C, Kucharz EJ, Richter J, Cozzi F, Rozman B, Mallia CM, Gabrielli A, Farge D, Kiener HP, Schöffel D, Airo P, Wollheim F, Martinovic D, Trotta F, Jablonska S, Reich K, Bombardieri S, Siakka P, Pellerito R, Bambara LM, Morovic-Vergles J, Denton C, Hinrichs R, Van den Hoogen F, Damjanov N, Kötter I, Ortiz V, Heitmann S, Krasowska D, Seidel M, Hasler P, Van Laar JM, Kaltwasser JP, Foeldvari I, Juan Mas A, Bajocchi G, Wislowska M, Pereira Da Silva JA, Jacobsen S, Worm M, Graniger W, Kuhn A, Stankovic A, Cossutta R, Majdan M, Damjanovska Rajcevska L, Tikly M, Nasonov EL, Steinbrink K, Herrick A, Müller-Ladner U, Dinc A, Scorza R, Sondergaard K, Indiveri F, Nielsen H, Szekanecz Z, Silver RM, Antivalle M, Espinosa IB, García de la Pena Lefebvre P, Midtvedt O, Launay D, Valesini F, Tuvik P, Ionescu RM, Del Papa N, Pinto S, Wigley F, Mihai C, Sinziana Capranu M, Sunderkötter C, Jun JB, Alhasani S, Distler JH, Ton E, Soukup T, Seibold J, Zeni S, Nash P, Mouthon L, De Keyser F, Duruöz MT, Cantatore FP, Strauss G, von Mülhen CA, Pozzi MR, Eyerich K, Szechinski J, Keiserman M, Houssiau FA, Román-Ivorra JA, Krummel-Lorenz B, Aringer M, Westhovens R, Bellisai F, Mayer M, Stoeckl F, Uprus M, Volpe A, Buslau M, Yavuz S, Granel B, Valderílio Feijó A, Del Galdo F, Popa S, Zenone T, Ricardo Machado X, Pileckyte M, Stebbings S, Mathieu A, Tulli A, Tourinho T, Souza R, Acayaba de Toledo R, Stamp L, Solanki K, Veale D, Francisco Marques Neto J, Bagnato GF, Loyo E, Toloza S, Li M, Ahmed Abdel Atty Mohamed W, Cobankara V, Olas J, Salsano F, Oksel F, Tanaseanu CM, Foti R, Ancuta C, Vonk M, Caramashi P, Beretta L, Balbir A, Chiàla A, Pasalic Simic K, Ghio M, Stamenkovic B, Rednic S, Host N, Pellerito R, Hachulla E, Furst DE. Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol. 2010 ;37:148. Impact factor- 3,551.
LN Moorthy1, Roy E1, MGE Peterson2, AL Hassett3, Susa Benseler, TJA Lehman2 and the members of our collaborative group….Ivan Foeldvari.. .4 . CONCISE REPORT Quality of life measure in rare systemic inflammatory pediatric rheumatic diseases and its translation to different languages – International effort. Pediatric Rheumatology online Journal 2014, 12 :49 (25 November 2014).
Gerd Horneff 1, K. Minden 2, I Foeldvari3, N Onken4, D. Windschall5, A. Hospach6, G. Ganser7, J. Klotsche8, I. Becker9 . Aktuelles aus dem BIKER-Register. Zeitschrift für Rheumatologie 2014, 73:897-906.
Ivan Foeldvari, Ingrid Becker, Gerd Horneff. Methotrexat seems to be protective to develop uveitis as an adverse event. Results from the German Biologics in Pediatric Rheumatology (BIKER) –Registry. Arthritis Care and Research e pub 2015 may 18.
Simon Tarp1, Gil Amarilyo2, Ivan Foeldvari3 N. Cohen2, T. D. Pope4, J. M. Woo4, Robin Christensen1, Daniel E. Furst4. Efficacy and safety of biologic agents for systemic juvenile idiopathic arthritis: A systematic review and meta-analysis of randomized trials. E pub in Rheumatology 2015 , nov 30th.
Simon Tarp1, Gil Amarilyo2, Ivan Foeldvari3 N. Cohen2, T. D. Pope4, J. M. Woo4, Robin Christensen1, Daniel E. Furst4. Efficacy and safety of biologic agents for systemic juvenile idiopathic arthritis: A systematic review and meta-analysis of randomized trials. Rheumatology 2016, 55: 669-679.
Tamas Constantin,1 Ivan Foeldvari,2 Jelena Vojinovic,3 Gerd Horneff,4 Ruben Burgos-Vargas,5 Irina Nikishina,6 Jonathan D Akikusa,7 Tadej Avcin,8 Jeffrey Chaitow,9 Elena Koskova,10 Bernard R Lauwerys,11 Inmaculada Calvo Penades,12 Berit Flato,13 Maria Luz Gamir,14 Hans-Iko Huppertz,15 Juan Jose Jaller Raad,16 Katerina Jarosova,17 Jordi Anton Lopez,18 Marie Macku,19 William J Otero Escalante,20 Lidia Rutkowska Sak,21 Ralf Trauzeddel,22 Patricia J Velez-Sanchez,23 Carine Wouters,24 Joseph Wajdula,25 Chuanbo Zang,25 Jack Bukowski,25 Deborah Woodworth,25 Bonnie Vlahos,25 Alberto Martini,26, 27 Nicolino Ruperto27 for the Paediatric Rheumatology International Trials Organisation (PRINTO). Two-year efficacy and safety of etanercept in paediatric patients with extended oligoarthritis, enthesitis-related arthritis or psoriatic arthritis. Journal of Rheumatology 2016, 43: 816-824.
Smith, Vanessa; Beeckman, Sam; Herrick, Ariane; Decuman, Saskia; Deschepper, Ellen; De Keyser, Filip; Distler, Oliver; Foeldvari, Ivan; Ingegnoli, Francesca; Müller-Ladner, Ulf; Riccieri, Valeria; Riemekasten, Gabriela; Sulli, Alberto; Voskuyl, Alexandre; Cutolo, Maurizio. An EULAR study group pilot study on reliability of “simple” capillaroscopic definitions to describe capillary morphology in rheumatic diseases. Rheumatology 2016, 55:883-890.
Horneff G, Klein A, Oommen P, Hospach A, Foeldvari I, Feddersen I, Minden K. Update on malignancies in children with juvenile idiopathic arthritis in the German BIKER Registry- Clinical Experimantel Rheumatology 2016, 34:1113-1120.
Otylia Kowal-Bielecka1, Jaap Fransen2, Jerome Avouac3, Mike Becker4, Agnieszka Kulak1, Yannick Allanore3, Oliver Distler5, Philip Clements6, Maurizio Cutolo7, Laszlo Czirjak8, Nemania Damjanov9, Francesco del Galdo10, Chris Denton11, Joerg Distler12, Ivan Foeldvari13, Kim Fligelstone14, Marc Frerix15, Daniel Furst6, Serena Guiducci16, Nicolas Hunzelmann17, Dinesh Khanna18, Marco Matucci-Cerinic16, Ariane Herrick19, Frank van den Hoogen2, Jaap van Laar20, Gabriela Riemekasten21, Richard Silver22, Vanessa Smith23, Alberto Sulli7, Ingo Tarner15, Alan Tyndall24, Joep Welling25, Frederic Wigley26, Gabriele Valentini27, Ulrich Walker24, Francesco Zulian28, Ulf Müller-Ladner15 on behalf of EUSTAR. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 2016. Epub Nov 9th 2016.
Gil Amarilyo, MD1*, Simon Tarp, MSc2*, Ivan Foeldvari, MD3, Neta Cohen, MD1, Tracy Danielle Pope, BS4, Jennifer Mei Ping Woo, MPH4, Robin Christensen, MSc, PhD2, Daniel Eric Furst, MD4 . Biologic agents in polyarticular JIA: a meta-analysis of randomized controlled trials. Semin Arthrits Rheum 2016, 46:312-8.
Dirk Holzinger1, Dirk Foell1, Gerd Horneff2, Ivan Foeldvari3, Nikolay Tzaribachev4, Catrin Tzaribachev4, Kirsten Minden5, Tilmann Kallinich5, Gerd Ganser6, Lucia Clara6, Johannes-Peter Haas7, Boris Hügle7, Hans-Iko Huppertz8, Frank Weller8, Alessandro Consolaro9,10, Francesca Bovis9, Nicolino Ruperto9 for the Paediatric Rheumatology International Trials Organisation (PRINTO). The German version of the Juvenile Arthritis Mulitdimensional assessment report (JAMAR). Accepted Rheumatology International 2017.
Francesca Ingegnoli1, Nicola Ughi1, Graham Dinsdale2, Annalisa Orenti3, Patrizia Boracchi3, Vanessa Smith4, Yannick Allanore5, Ivan Foeldvari6, Alberto Sulli7, Maurizio Cutolo7, Ariane L Herrick2,8, on behalf of the EULAR Study Group on Microcirculation in Rheumatic Diseases. An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud’s phEnomenon (SUNSHINE survey). Accepted Rheumatology International 2017.
Gerd Horneff; Ariane Klein; Gerd Ganser; Michaela Sailer-Hoeck; Annette Guenther; Ivan Foeldvari; Frank Weller-Heinemann. Protocols on classification, monitoring and therapy in children’s rheumatology (PRO-KIND): Results of the working group Polyarticular juvenile idiopathic arthritis. Pediatric Rheumatology 2017, 15:78.
Horneff G1 Schulz AC1, Klotsche J3, Hospach A2, Minden K3, Foeldvari I4, Trauzeddel R5, Ganser G6, Weller-Heinemann F7, Haas JP8. Experience with Etanercept, Tocilizumab and Interleukin-1 inhibitors in systemic onset Juvenile Idiopathic Arthritis patients from the BIKER registry. ARRT-D-17-00231R2 in Arthritis Research & Therapy.
Shenoi S, Horneff G, Cidon M, Ramanan A, Kimura Y, Quartier P, Foeldvari I,… Wulfraat N. The Burden of Systemic Juvenile Idiopathic Arthritis (SJIA) for Patients and Caregivers: An International Survey and Retrospective Chart Review- Clinical and Experimental Rheumatology accepted 2017.
Tamás Constantin,1 Ivan Foeldvari,2 Jordi Anton,3 Joke de Boer,4 Severine Czitrom-Guillaume,5 Clive Edelsten,6 Raz Gepstein,7 Arnd Heiligenhaus,8,9 Clarissa Pilkington,10 Gabriele Simonini,11 Yosef Uziel,12 Bas Vastert,13 Nico Wulffraat,13 Anne-Mieke Haasnoot,4 Karoline Walscheid,8 Annamária Pálinkás,14 Reshma Pattani,15 Zoltán Györgyi,16 Richárd Kozma,17 Victor Boom,13 Andrea Ponyi,1 Angelo Ravelli,18 Athimalaipet V Ramanan19. Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis. Ann Rheum Dis 2018, 77:1107-1117.
Tamás Constantin, Ivan Foeldvari, Clare E Pain, Kathryn S. Torok, Annamária Pálinkás, Peter Höger, Monika Moll, Dana Nemkova, Lisa Weibel, Melinda Laczkovszki, Philip Clements. Development of Minimum Standards of Care for Juvenile Localized Scleroderma. European Journal of Pediatrics: 2018, 177,961-977.
Sandra Schenck1, Joachim Rosenbauer2,3, Martina Niewerth1, Jens Klotsche1,4, Kirsten Minden1,5, Tobias Schwarz6, Ivan Foeldvari7, Gerd Horneff8, Frank Weller-Heinemann9, Reinhard W. Holl10, Angelika Thon11 Comorbidity of type 1 diabetes mellitus in patients with juvenile idiopathic arthritis. Journal of Pediatrics. 2018,192:196-203.
Timothy Beukelman, Fenglong Xie, Ivan Foeldvari. Assessing the Prevalence of localized scleroderma in childhood using Administrative Claims Data from the United States. Journal of Scleroderma and Related Disorders 2018, I-2, DOI: 10.1177/2397198318798588.
I. Foeldvari. TNF- ? Antagonisten in der Kinderrheumatologie. Symposium medical 2004, 15: 32-33.
I Foeldvari – Koauthor an den nationalen Leitlinien des Kutanen Lupus Erythematodes. Entwicklungsstufe 1. – www.awmf.org/ www.derma.de – Annegret Kuhn1*, Merle Haust2, Elisabeth Aberer3, Caroline Barde4, Ivan Foeldvari5,Christof Iking-Konert6, Peter Kind7, Alexander Kreuter8, Percy Lehmann9, Thomas Luger1, Jann Lübbe4, Michael Meurer10, Ulf Müller-Ladner11, Falk Ochsendorf12, Vincent Ruland1, Thomas Ruzicka13, Matthias Schneider6, Michael Sticherling14, Beate Tebbe15, Jörg Wenzel16, Annette Wons1, Elke Weisshaar17, Gisela Bonsmann1Kutaner Lupus erythematodes: Teil 1. Diagnostik + Teil 2. Therapie. AWMF Leitlinien Stufe 1..
A. Kienast. I Foeldvari. Hauterscheinungen bei rheumatischen Erkrankungen im Kindes und Jugendalter. Kinder- und Jugendarzt 2013, 44, 149-156.
Tamas Constantin, Gyorgyi Zoltan, Ivan Foeldvari, Peter Weiser, Andras Szabo Recent advance in Systemic Scleroderma in Childhood. Annals of Paediatric Rheumatology. Accepted APR-2014-08-018.
I. Foeldvari Update on Juvenile Systemic Sclerosis. Current Rheumatology Reports. 2015, 17:18.
I Foeldvari. Managing uveitis in patients with juvenile idiopathic arthriits. Expert Opinion on Orphan Drugs. Accepted 07th April 2016.
I. Foeldvari . Scleroderma in childhood: Systemic form – Evaluation and Management – Chapter in Pediatric Rheumatology: A Clinical Viewpoint. Springer Verlag 2016.
Knobler, R; Moinzadeh, P; Hunzelmann, N ; Kreuter, A; Cozzio, A ; Mouthon, L; Cutolo, M; Rongioletti, F; Denton, C P; Rudnicka, L; Frasin, L A; Smith, V; Gabrielli, A; Aberer, E; Bagot, M; Bali, G; Bouaziz, J; Braae Olesen, A; Foeldvari, I; Frances, C; Jalili, A; Just, U; Kahari, V; Karpati, S; Kofoed, K; Krasowska, D; Olszewska, M; Orteu, C; Panelius, J; Parodi, A; Petit, A; Quaglino, P; Ranki, A; Sanchez Schmidt, J M; Seneschal, J; Skrok, A; Sticherling, M; Sunderkotter, C; Taieb, A; Tanew, A; Wolf, P; Worm, M; Wutte, N J; Krieg, T. European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol. 09 August 2017.
Knobler, R; Moinzadeh, P; Hunzelmann, N ; Kreuter, A; Cozzio, A ; Mouthon, L; Cutolo, M; Rongioletti, F; Denton, C P; Rudnicka, L; Frasin, L A; Smith, V; Gabrielli, A; Aberer, E; Bagot, M; Bali, G; Bouaziz, J; Braae Olesen, A; Foeldvari, I; Frances, C; Jalili, A; Just, U; Kahari, V; Karpati, S; Kofoed, K; Krasowska, D; Olszewska, M; Orteu, C; Panelius, J; Parodi, A; Petit, A; Quaglino, P; Ranki, A; Sanchez Schmidt, J M; Seneschal, J; Skrok, A; Sticherling, M; Sunderkotter, C; Taieb, A; Tanew, A; Wolf, P; Worm, M; Wutte, N J; Krieg, T. European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis. J Eur Acad Dermatol. 08 August 2017.
C. Loeliger, I Foeldvari: Caucasian German juvenile rheumatoid arthritis. In P.I. Terasaki, D.W. Gjertson, Herausgeber. HLA 1997. Los Angeles: UCLA Tissue Typing Laboratory; 1997:407-8.
I. Foeldvari: Sklerodermie. In Rheumatische Erkrankungen des Kindes- und Jugendalter. München: Hans Marseille; 2001:296-303.
I. Foeldvari. Sklerodermie und Sharp-Syndrom im “N. Wagner und G. Dannecker : Pädiatrische Rheumatologie- Buch, Springer 2007: 347-363.
I. Foeldvari. Juvenile Systemic Sclerosis. Im Handbook of Systemic autoimmune diseases- Pediatrics. – First Edition – Elsevier 2008. 107-118. Herausgeber: T. Lehmann und R. Cimaz.
Foeldvari. An 8-year-old girl with tight skin, digital ulcers, and dysphaiga. Case Studies in Systemic Sclerosis. Editors: Richard M. Silver and Christpher P. Denton. Springer 2011.
I. Foeldvar. Juvenile systemic sclerosis. Page 93-103. Scleroderma – From Pathogenesis to comprehensive management. Editors J. Varga, C.P. Denton, F.M. Wigley. Springer 2012.
I. Foeldvari. Up Date on Juvenile Systemic Sclerosis. Ebook chapter. Cutolo et al. 2013. Future in Medicine.
I. Foeldvari . Scleroderma in childhood. Manual in Pediatric Rheumatology. Ebook. Editor S. Sawhney and A. Aggarwal.
Kienast A1, Foeldvari I1. Sklerodermie im Kindes- und Jugendalter: Diagnose, Behandlung und Prognose (Scleroderma in children and adolescents). Pädiatrische Praxis 2015, 84.319-328.
Foeldvari I, Ponya A. Scleroderma Spectrum Korkepie. Klinikai gyermekgyógyászat (Buch) 13. Chapter ( 2016) :266-269.
I Foeldvari. Juvenile systemic Sclerosis. Pediatrics in Systemic Autoimmune Diseases. ISBN 978-0-444-63596-9.
Fifth International Workshop on Scleroderma Research, July 19-21, 1998 Boston, Massachusetts, unterstützt vom National Institute of Health: „Survival in Pediatric Scleroderma“.
Veranstaltung des Norddeutschen Zentrums zur Weiterentwicklung der Pflege: “Kinder-Welt”, workshop: „Diagnose: Lebenslänglich” (11/98).
Regionaltagung der Deutschen Gesellschaft für Rheumatologie, Warnemünde, 1999: Organisation und Vorsitz des Symposium der Arbeitsgemeinschaft Kinderrheumatologie, „Rationale Diagnostik der Gelenkbeschwerden im Kindes- und Jugendalter“ (Vortrag zusammen mit Dr. Dressler) (Zeitschrift für Rheumatologie, 1999, 58 (Suppl 1):I/19 S 44).
„Transition Clinics für adoleszente Patienten“.
Der besondere Fall. Aplastische Anämie und Thrombotische Thrombozytopenische Purpura bei einer Patientin mit systemischem Lupus erythematosus. Symposium der Arbeitsgemeinschaft Kinder- und Jugendrheumatologie und der Niederländischen Arbeitsgemeinschaft Pädiatrische Rheumatologie. 21.01.2000, Sendenhorst.
Scleroderma in Childhood. An Overview. National Paediatric Rheumatology Teaching Course at Great Ormond Street Hospital, in Cooperation with The Institute of Child Health, 02.24.2000, London, UK.
Juvenile systemic sclerosis. An overview. Grand rounds. Children´s Hospital of Phialdelphia, University of Pennsylvania, Philadelphia, USA. 27. 03.2000.
Results of the Phase I/II Study for Meloxciam, International Investigator Meeting Meloxicam, Boehringer Ingelheim, 02/02/2001, München, Germany.
Erste Ergebnisse der Anwendung von selektiven COX-2-Hemmern in der Kinderrheumatologie. 21.09.01, 30. Kongress der Deutschen Gesellschaft für Rheumatologie, Leipzig. Zeitschrift für Rheumatologie, 2001, 60, Suppl 1: I/16.
Systemischer Lupus Erythematodes bei Neugeborenen und im Kindesalter. Veranstaltung zum 10-jährigen Jubiläum der Regionalgruppe Hamburg, LUPUS Erythematodes – Selbsthilfegemeinschaft. e.V. 24.08.02, Hamburg.
COX-2 Hemmer bevorzugt? Eine kritische Bestandsaufnahme. Mittagssymposium, Deutscher Orthopädenkongress 2002 Berlin.
Corticoidinduzierte Osteoporose bei juveniler rheumatoider Arthritis. Seminar des Regionalen Expertenkreises Osteoporose – Mitteldeutschland, 16.11.2002, Hannover.
Juvenile Systemische Sklerodermie. 6. Kurs Pädiatrische Rheumatologie, 22.-23.11.2002, Bremen.
Ambulante Versorgung rheumakranker Kinder. Symposium Rheuma bei Kindern – Neue Wege. Universitätskinderklinik Greifswald 08.02.2003.
Immunsuppressive Therapie bei der kindlichen Uveitis. Fortbildung zum Thema Uveitis- aktuelle Aspekte. Universitäts-Augenklinik Hamburg-Eppendorf, 22.02.2003.
Results of treatment with methotrexate for uveitis associated to juvenile idiopathic arthritis. Grand rounds. Rheumatology Department,MUSC, Charleston, South Carolina, 20.03.2003.
Juvenile systemic sclerosis: clinical and laboratory features and outcome. Grand rounds, University Children´s Hospital, Padua, Italien, 30.05.2003.
Klinische Präsentation, Therapie und Prognose der kindlichen systemischen Sklerodermie. 13. Jahrestagung der Arbeitsgemeinschaft für Kinder und Jugendrheumatologie. Aktuelle Rheumatologie, 2003, 28: 279, E.1.
Pediatric skin scoring. OMERACT 7, 2004, Monterey , California, USA.
Labordiagnostik von Autoimmunerkrankungen im Kindesalter. – Workshop – 12. Jahrestagung der Arbeitsgemeinschaft Pädiatrische Dermatologie, 09/2004.
Sklerodermie im Kindesalter. Wörlitzer Gespräche, 02.10.2004.
Update on uveitis treatment . National Brasilian Rheumatology Meeting, October 2004, Rio de Janeiro, Brasil.
Scleroderma in children. Nationale Brasilian Rheumatology Meeting, October 2004, Rio de Janeiro, Brasil.
Juvenile systemic sclerosis: Presentation of the planned inception cohort project. 1st Joint Cooperation Meeting of the German Network for Systemic Sclerosis (DNSS), Scientific Advisory Board, Köln, 17-18. December 2004.
Das Hamburger Diagnostik- und Therapiekonzept für Kinder und Jugendliche mit juveniler idiopathischer Arthritis. 21.001.2005, Universitätsklinikum Hamburg-Eppendorf, Zentrum für Zahn-, Mund- und Kieferheilkunde.
Scleroderma: how will we now learn more about this rare disease? – Old Challenges and New Directions in pediatric Rheumatology“ – Ross Petty Tribute Symposium 02.04.2005, Vancouver, Canada.
Aktuelle Aspekte der Uveitisbehandlung bei Kindern – Immunomodulation. Am 22.06.2005- Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Augenheilkunde.
Formen der Sklerodermie im Kindesalter- Guide zum praktischen Vorgehen- Symposium Kinder- und Jugendrheumatologie- am 10.09.05 Klinik Sankt Augustin, Sankt Augustin.
Sklerodermie im Kindesalter. 4. Erfurter Symposium – Autoimmunerkrankungen im Kindes und Jugendalter. 05.11.2005, Erfurt.
Juvenile idiopathische Artritis – Therapie der Uveitis assoziiert zu JIA. Uveitis Seminar der Deutschen Arbeitsgemeinschaft für Uveitis und der Uveitis Selbsthilfegruppe in Zusammenarbeit mit der Universitäts Augenklinik Hamburg Eppendorf. 26.-27.11.2005 Hamburg.
The eye in systemic disease – Is there an effective immunopsuppressive treatment for juvenile idiopathic arthritis associated uveitis? – II Congresso Latino-Americano De Autoimmunidade, Rio de Janiero, 28-30.04.2006, Brasilien.
Systemic Sclerosis in childhood – Professor E. Carwile LeRoy Memorial International workshop on Scleroderma. 17.-20.05.2007 , Tokyo, Japan.
What makes children so spezial as patients? – Workshops on inflammatory disese in childhood: future challenges in paediatric uveitis. Annual Meeting of the European Society of Ophthalmology and the American Academy of Opthalmology. Wien 12.06.07.
Juvenile Sklerodermie. 35. Kongress der Deutschen Gesellschaft für Rheumatologie, Hamburg, 19.-22.09.2007.
Juvenile Skleroderma – DROP 2007 . Debrecen. Ungarn.. 16.11.2007.
Therapie der juvenilen idiopathischen Arthritis. –Plenary Session- Jahresversammlung der ungarischen Kinderrheumatologen. Budapest. Ungarn. 01.12.,2007.
Diagnose und Behandlung der juvenilen idiopathischen Arthritis assoziierten Uveitis.
25.04.2008, Barcleona. I. Reunion Nacional. Uveitis asociade a Arthritis Idiopatica Juvenil.
Skin scores: what it tells us in adults in children. Invited speaker for the 15th Paediatric Rheumatology European Sociatey Congress. London 14.-17.09.2008.
Systemic Sclerosis World Symposium. Pediatric workshop- Clinical Presentation of juvenile systemic sclerosis . Organised by Actelion. Basel,Switzerland. 27.02.-01.03.2009.
2. Symposium – “Sport & Rheuma bei Kindern”- JIA: Wie sollen wir bei der Sport-Beratung vorgehen?- Garmisch-Partenkirchen, 09.05.09.
Biologics in JIA. Kolloquium- The Impact if Biologics in the treatmet of arthritis. Technische Universität Zürich, Schweiz 01.10.09. I. Foeldvari. Bilogics in JIA.
Sklerodermie und Kollagenosen –ZNS- Komplikation im Kindes- und Jugendalter.- Halle 26.02.10.- Symposium- Pädiatrische Neuromimmunologie“.
Rheumatologische Diagnositik für benachbarte Fachdisziplinen. 2. Kieler CMD Konferenz – 19.-20.03.10.
Faculty on the EUSTAR/EULAR course for the lecture: juvenile systemic scleoris, Belgrad, Serbia, 2011.
Outcome Measures in Uveiits associated to juvenile idiopathic Arthritis. PRES Meeting Valencia 9.-12 09.2010.
Enviromental influence on clinicla picture of FMF. 2 nd International Education meeting on Peridoidc Fever Syndromes and autoinfalmmatrory diseases. Budapest, Hungary. 22nd of October 2011.
Adaptation and Validation of Outcome Measures for Pediatric Uveitis. Pediatric Rheumatology study group at the American College of Rheumatology Meeting. 2011 Chicago, USA.
Specific features of juvenile scleroderma. Annual meeting of the Groupe Francais de Recherche sur la Sclerodermie. 22nd of November 2011, Paris, France.
Faculty on the EUSTAR/EULAR course for the lecture: juvenile systemic scleoris, Cluj, Romanie, 2013.
How to access systemic treatment efficacy in juvenile idiopathic arthritis associated arthritis. Plenary session talk. Second International congress on Controverises in Rheumatology & Autoimmunity (CORA) meeting, Budapest 2013.
Sklerodermie: Neue Therapien und deren Risiken- besondere Aspekte für juvenile systemische Sklerodermie. DGRH /GKJR Kongress – Mannheim 20.09.2013.
Activity and damage – We have to measure them- Juvenile Systemic Sclerosis. Plenary Session talk. Annual Pediatric Rheumatology European Society Meeting 28th of September, Ljubjana, Slovenia.
39. Garmisch-Partenkirchner Symposium für Kinder- und Jugendrheumatologie. Juvenile Sklerodermie- ein Update. 18.01.2014.
3. Systemic Sclerois World Congress , Rome, Italy 2014: Systemic involvement in localised scleroderma.
3. Systemic Sclerois World Congress , Rome, Italy 2014: Is juvenile systemic sclerosis a diferent disease from the adult onset disease? Clinical outcome data.
3. Systemic Sclerois World Congress , Rome, Italy 2014 – Patient Programm: Juvenile Scleroderma.
Annual Russion Meeting of Pediatric, Moscau, Russia 15.02.14: Methotrexate in Juvenile Rheumatic Diseases.
Annual Meeting of European Society Pediatric Dermatology (ESPED) 14.06.2014 Kiel- Rheumatic Disease…. Skin.
Annual Pediatric Rheumatology European Sociaty Meeting. Belgrad, 17.-21.09.2014. Outcome measures in JIA associated Uveitis.
Brasilian Rheumatology Meeting, Bella Horisonte , 1.-4.10.2014. Review of juvenile Scleroderma.
Brasilian Rheumatology Meeting, Bella Horisonte , 1.-4.10.2014. Review of treatment of uveitis.
EULAR 2015 Rome, 10-13.06.2015. Juvenile systemic sclerosis. Plenary session talk.
EULAR 2015 Rome, 10-13.06.2015. Scleroderma like fibrosing diseases. Plenary session talk.
DGRH Kongress Bremen 02.-05.09.15. Therapierefraktäre Uveitis. Plenary session.
1st Central European Basic Course in Pediatric Rheumatology, Budapest Hungary 26-29th of November, 2015. Juvenile Scleroderam , Raynuad Phenomenon. Plenary Session talk.
XIX Congress of Pediatricians of Russia. Mokva 12-14th of February, 2016. Plenary session in Actual Problems of Pediatrics. Methotrexate usie in juvenile rheumatic diseases.
4th Systemic Sclerosis World Congress, 18-20th Februaray 2016, Lissabon. Session Localised Scleroderma Diagnosis, Classification and Therapy. Selected case presentation difficult treatment decisions.
4th Systemic Sclerosis World Congress, 18-20th Februaray 2016, Lissabon. FESCA session: Juvenile Scleroderma.
7th EULAR course on Capillaroscopy 8-10th of January 2016, Genua, Italy. Raynaud Phenomenon in Children.
19. Komplikationen bei der Erkrankung mit kindlicher Sklerodermie Risikofaktoren für einen schwereren Verlauf. DGRH plenary session. Stuttgart 7th – 10th of September, Stuttgart Germany.
19. Aktuelles zu Diagnose, Differentialdiagsnose und Therapie der Uveitis. Aus Sicht der Kinderrheumatologen. Hamburger Augenärztliche Fortbildung am UKE. 16.09.17. Hamburg, Germany.
Juvenile idiopathic arthritis associaeid uveitis from the perspective of the Pediatric Rheumatologist. In tema di Malattie rare Pediatriche. Uveite infiammatorica cronica dellìnfanzia: un pradigma. 05.12.17 Fondazione Meyer, Florence, Italy.
„Use of Biologics in Paediatric Rheumatology“ . „JIA associated Uveitis“ and „Approach & Management of musculoskeletal Pain in children“. Solo Speaker on the Paediatric Rheumatology Symposium by The Hong Kong Society of Paedaitric Rheumatology.Invited Speaker, 27.01.2018, Hong Kong.
Resultados da coorte internacional de escleroderma. XXXV. Brasilian Rheumatology Congress .08.09.2018 Rio de Janeiro, Brazil.
Share Recommendation for juvenile Scleroderma. Brasilian Rheumatology Congress, 08.09.2018 Rio de Janeiro, Brazil.
Diagnostico de escleroderma na infancia. Brasilian Rheumatology Congress , 08.09.2018 Rio de Janeiro, Brazil.
Raynaud´s in Childrens: the size of the problem and new guidelines. 8 th EULAR course of capillaroscopy in Rheumatic Diseases. 13-15th of September, 2018, Genua, Italy.
J. Dippel, I. Foeldvari: Therapie der Juvenilen Polyartikulären Chronischen Arthritis. Jahrestagung der Deutschen Gesellschaft für Kinderheilkunde, Ulm 1989.
I. Foeldvari, Y. Kimura, J.C. Jacobs: Macht Komplementdefizienz anfällig für SLE im Kindesalter? 1. Jahrestagung der Deutschen Gesellschaft für Kinderrheumatologie, Göttingen, 1991.
I. Foeldvari: Häufigkeit von Antiphospholipid-Antikörpern bei kinderrheumatologischen Patienten. 2. Jahrestagung der Deutschen Gesellschaft für Kinderrheumatologie, Göttingen, 1992.
I. Foeldvari, C. Loeliger: Auffällige Häufung von Antiphospholipid-Antikörpern bei Eltern von Kindern mit juveniler oligoartikulärer Arthritis und SLE und deren Korrelation mit HLA-Loci. Vortrag zur 89. Jahrestagung der Kinderheilkunde Würzburg. Monatsschrift der Kinderheilkunde, 1993,141: (Supplement 1) 051 .
I. Foeldvari, N. Birdi, P.B. Dent, R. Elborgh, F. Falcini, R. Häfner, R. Joos, A.M. Prieur, K. Rostropowicz-Denisiewicz, A. Savolainen, A. Siamopoulou-Mayridou, F. Zulian, R.E. Petty: Outcome of progressive systemic sclerosis (PSS) in childhood: Results of a multi-national questionnaire. (präsentiert zur “3. European Conference on Pediatric Diseases and Allied Disorders, 9/1995; Gent, Belgium. Clin Exp Rheumatol 1995;13: 554.
I. Foeldvari, U. N. Birdi, P.B. Dent, R. Elborgh, F Falcini, R. Häfner, R. Joos, A.M. Prieur, K. Rostropowicz-Denisiewicz, A. Savolainen, A Siamopoulou-Mayridou, F. Zulian, R.E. Petty: Progressive Systemische Sklerodermie (PSS) bei 94 Kindern: Ergebnis einer multinationalen Studie. Vortrag zur 5. Jahrestagung der Deutschen Gesellschaft für Kinderrheumatologie, Freiburg i.Br., 1995, Monatsschrift Kinderheilkunde 1995; 143: 1052 V18.
I .Foeldvari, C. Soost, R. Klein, C. Loeliger: Assoziation des Auftretens von Antiphospholipid-Antikörpern mit HLA-Merkmalen bei Kindern mit rheumatologischen Erkrankungen und ihren Eltern. Vortrag zur 6. Jahrestagung der Deutschen Gesellschaft für Kinderrheumatologie, Mühlheim an der Ruhr, 1996. Monatsschrift der Kinderheilkunde 1996; 144:1295.
I. Foeldvari, M. Zhavania, N. Birdi, R.J. Cuttica, S.H.F. de Oliveira, P.B. Dent, R. Elborgh, F. Falcini, G. Ganser, H. Girschick, R. Häfner, R. Joos, W. Kuis, P. Pelkonen, A.M. Prieur, K. Rostropowicz-Denisiewicz, R. Russo, A. Savolainen, A. Siamopoulou-Mayridou, F. Zulian: Günstigere Überlebenschance bei 135 Patienten mit juveniler systemischer Sklerodermie (jSSc): Ergebnisse einer multinationalen Studie. 8. Jahrestagung der Arbeitsgemeinschaft für Kinder- und Jugendmedizin, 10/98 Cottbus.
I. Foeldvari., M. Redegeld, M. Mehrwald, D. Hülsebus, M. Bullinger. Gesundheitsbezogene Lebensqualität von Rheuma-betroffenen Kindern und Jugendlichen aus Elternsicht. Jahrestagung der Arbeitsgemeinschaft Kinder- und Jugendrheumatologie und Pädiatrische Immunologie, Tübingen Mai 2000.
B. Finckh, I. Foeldvari, D. Huelsebus, M. Mehrwald, A. Kohlschütter: Changes of antioxidative status and lipid peroxidation in juvenile idiopathic arthritis over a period of three months. 10th Biennial Meeting of the International Society for Free Radical Research. Abstract No. 002-5 (Reference No.: 100) Kyoto, Japan, 10/2000.
G. Horneff, I. Foeldvari, R.M. Küster, H. Michles, D. Moebius, H. Schmeling, A. Thon: Etanercept for the treatment of juvenile idiopathic arthritis: results of the German registry. Ann Rheum Disease 2002, 61,Suppl 1: 52 – OP 0062.
I. Foeldvari: Es zeigt sich eine sehr gute Verträglichkeit von Vioxx? in der Anwendungsbeobachtung. 12. Jahrestagung der Arbeitsgemeinschaft für Kinder- und Jugendrheumatologie. Aktuelle Rheumatologie 2002, 27 :276 (36).
K. Minden, M. Niewerth, G. Ganser, RM Küster, D. Möbius, I. Foeldvari, A. Zink: Therapiekontinuität bei der juvenilen idiopathischen Arthritis. 13. Jahrestagung der Arbeitsgemeinschaft für Kinder und Jugendrheumatologie. Aktuelle Rheumatologie, 2003, 28: 282, F.6.
I. Foeldvari, A. Wierk. Results of leflunomide (LEF) therapy in patients with juvenile idiopathic arthritis (JIA): A pilot noncontrolled therapeutic intervention. EULAR 2004 , Berlin, Ann Rheum Dis 2004, 61 (Supll 1.): 80 – OP 0076.
I. Foeldvari, A. Wierk. Kann man in der pädiatrischen Population den modifizierten Rodnan Skin Score ohne Adaptation anwenden? Zeitschrift für Rheumatologie 2004, 63: 274- F.3.
N.Ruperto, DJ. Lovell, S. Goodmann, A. Reiff, L. Jung, D.Nmecova, K. Jarosova, AM: Prieur, C. Sandborg, R. Joos, I. Foeldvari, et,al. Preliminary data from the open label phase of he randomized trial of adalimumab in children with juvenile idiopathic arthritis. PRES 2004, Kosice, Slovakia. Clin exp Rheum 2004, 22:522.
I. Foeldvari, A. Wierk: Helathy children have a significantly increased skin score assessed with the modified Rodnan skin score. PRES 2004, Kosice, Slovakia. Clin exp Rheum 2004, 22:527.
N. Ruperto, A. Ravelli, S.Olivieri, E. Silverman, G. espada, D. Mihaylova, S. Pasic, S. Ozen, M. Apaz, B. Bica, D. nemcova, R. Burgos-Varagas, F. Corona, AM. Romicka, J. Consuegra, S. Hagleberg, C Da Silva, C. Coto, Y. Uziel, J. Ros, MI. Gamir, I. Foeldvari, et, al. The validated PRINTO core set and definition of improvement for juvenile systemic lupus erythematosus. PRES 2004, Kosice, Slovakia. Clin exp Rheum 2004, 22:510.
G. Horneff, R. Küster, H. Girschick, I. Foeldvari, D. Moebius. Safety of etanercept for treatment of juvenile idiopathic arthritis (JIA) – data of the German etanercept JIA registry. EULAR 2005, Wien , Österreich. Ann Rheum Dis 2005, 64 , Supplement III: 72 – OP 0048.
C. Boschau, O. Witt, L. Schweigerer, P. Lohse, I. Foeldvari, H. Zappel. Neonatal-onset multisystem inflammatory disease (NOMID): new mutation of the CIAS1 gene and response to interleukin-1 recptor antagonist treatment. 15. Tagung der Arbeitsgemeinschaft für Kinder- nd Jugendrheumatologie, 2005 Dresden. Zeitschrift für Rheumatologie 2005, 64 (Suppl 1): FKJ3-3, I/29.
I. Foeldvari, S. Nielson, J. Kümmerle-Deschner, T. Sauerenman. Ergebnisse der multinationalen Befragung über die Anwendung der Tumor Nekrosis Faktor alpha Blocker in der Behandlung der JIA assoziierten Uveitis. 15. Tagung der Arbeitsgemeinschaft für Kinder- nd Jugendrheumatologie, 2005 Dresden. Zeitschrift für Rheumatologie 2005, 64 (Suppl 1): FKJ3-7, I/30.
M. Niewerth, K. Minden, I. Foeldvari, G. Ganser, A. Zink. Übergewicht – ein Thema bei rheumakranken Kindern und Jugendlichen? Gewichtsstatus bei Patienten mit juveniler idiopathischer Arthritis. 15. Tagung der Arbeitsgemeinschaft für Kinder- nd Jugendrheumatologie, 2005 Dresden. Zeitschrift für Rheumatologie 2005, 64 (Suppl 1): FKJ2-5, I/28.
F. Zulian, P. Woo, B.H. Athreya, R. laxer, T.A. Medsger, T.A. Lehman, M. Matucci-Cerinic, G. Martini, A. Ravelli, R. Russo, R. Cuttica, S.F.K. De Oliveira, C. Denton, I. Foeldvari, N. Ruperto. Preliminary classification criteria for systemic sclerosis in children. XII. European Pediatric Rheumatology Congress, Versaille, Frankreich 2005. Clinical Exp Rheumatol 2005; 23 (Suppl 37): S-47.
G. Horneff, H. Girschick, I. Foeldvari, H. Michels, B. Rogalski, H. Schmeling: Combination therapy with etanercept and methotrexate compared to etanercept monotherapy in patients with juvenile idiopathic arthritis. 2005 Annual Scientific Meeting of the American College or Rheumatology, San Diego, Ca., USA. Arthritis Rheum 2005, 52 (Suppl): A 1955.
N. Ruperto, D.J. Lovell, S. Goodman, A. Reiff, L.Jung, D: Nemcova, K. Jarosova, A. Prieur,C. Sanborg, R. Joos, I. Foeldvari, V. Gerloni, J. Rovensky, J. Bohnsack, K.Minden, L. Wagner-Weiner, R. Vehe, H. Huppertz, G. Horneff,N. Olson, J. Medich, E.H. Giannini, A. Martini: 48 week data from the study of adalimumab in children with juvenile rheumatoid arthritis. Annual European Congress of Rheumatology, 2006, Amsterdam, Holland. Ann Rheum Dis 2006, 65 Suppl II: 56.
I.Foeldvari, A. Heiligenhaus, C.Tappeiner,S. Nielson, N. Tzaribachev, J. Quitsch, F. Dressler, M.O. Hilario, R.M. Küster, M. Borte, H. Mazu, E. Jäger-Roman, A. Wierk: Ergebnisse einer mulitnationalen Befragung zur Anwendung von Cyclopsporinb-A (CSA) in der Behandlung von Uveitis assoziiert mit juvenilen idiopathischen Arthritis (JIA). 16. Jahrestagung der Gessellschaft für Kinder- und Jugendrheumatologie , Leipzig 2006. Kinder- und Jugendmedizin 2006; 6: A 50, Abstact 39.
G. Horneff, I. Foeldvari, J. Roth, H. Michels, M. Borte, H. Schmeling. Efficacy and tolerability of etanercept in children with juvenile idiopathic arthritis below the age of 4 years. 2006 Annual Scientific Meeting of the American College of Rheumatology, Washington. Arth Rheumatism 2006, 54 (Suppl):S327 A 722.
O. Kowal-Bielecka, R. Landews, J. Avouac, S. Chwiesko, L. Miniati, L. Czirjak, P. Clements, C. Denton, D. Farge, K. Fligelstone, I. Foeldvari,… et al. EULA/EUSTAR recommendation for the management of systemic sclerosis. THU0281, EULAR 2007 Barcelona.
I. Foeldvari, C. Wotuers, T. Avcin, F. Zulian. Results of a multinationla survey regarding preferences of paediatric rheumatologists in the treatment of juvenile systemic sclerosis. OPO185, EULAR 2007, Barcelona.
F.Zulian, O.Kowal-Bielecka, I. Miniati, J. Avouac,SChwiesko, A. Aggarwal, BH Atreya, T. Avcin, R. Cuttica, SDKF de Oliveira, G. Higgins, RM Laxer, C. Lindsley, TH Lehman, G Martini, A Ravelli, R Russ, Y Uziel, C Wouters, I Foeldvari, EUSTR/Eular commitess on SSc management recommendations. Preliminary agreement of the Pediatric Rheumatology European Society(PRES) in the EUSTAR/EULAR redommendations for the management of systemic sclerosis in children. OP-17 on the 14 th European Pediatric Rheumatology Congress, Istanbul, Turkey. 2007.
I Foeldvari, C Wouters, T Avcin, F Zulian. Results of a multinational survey regarding preferences of paediatric rheumatologists in the treatment of juvenile systemic sclerosis. OP-19 on the 14 th European Pediatric Rheumatology Congress, Istanbul, Turkey. 2007.
I Foeldvari, A Wierk. Leflunomide is an effective alternative in the treatment for patients with juvenile idiopathic arthritis. OP-30 on the 14 th European Pediatric Rheumatology Congress, Istanbul, Turkey. 2007.
I. Foeldvari. The prospective juvenile systemic sclerosis inceptions cohort. 1st Conference on Translational Research I Pediatric Rheumatology. Genoa , Italy.2008.
D Lovell, R Cuttica, P Woo, G Espada, C Wouters, ED Silverman, Z Balogh, M Henricksen, J Davidson, I Foeldvari, L Imundo, G Simonini, J Oppermann, YK Shen, S Visvanathan, A Fasanmade et al. Long term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course JRA: findings from the open label treatment extension. Annual PRES meeting London, UK 2008.
EULAR 2009 [THU0413], Copenhagen, Denmark.
N. Ruperto, D.J. Lovell, R. Mouy, E. Paz, N. Rubio-Perez, C.A. Silva, C. Abud-Mendoza, R. Burgos-Vargas, V. Gerloni, J.A. Melo-Gomes, C. Saad-Magalhaes, J. Chavez1, C. Huemer, A. Kivitz, F. Blanco, I. Foeldvari, M. Hofer, G. Horneff1, H. Huppertz, C. Job Deslandre, K. Minden, M. Punaro, A. Flores Nunez, L.H. Sigal, A.J. Block, A. Covucci, A. Martini, E.H. Giannini. Long-term safety and efficacy of abatacept in subjects with polyarticular juvenile idiopathich arthritis. OP- 0268 EULAR 2009 [THU0413], Copenhagen. Denmark.
J.B. Kuemmerle Deschner, R. Cartwright, M. Gattorno, F. Zulian, P. Quartier, J. Hoyer, I. Foeldvari, E. Ramos, P.N. Hawkins, K. Leslie, G. Krammer, S. Malfait, R. Preiss, A. Widmer and E. Hachulla. Safety and effecacy of canakinumab in children accross different disease severity and phenotypes of cryopyrin associated periodic syndrome (CAPS): intermin results of an ongoing study. ACR 2009 Philadelphia, USA, Arthritis Rheum 2009, 60: #2056.
P Quartier, E Hachulla, M Gattorno, R Cartwright, I Kone-Paut, F Zulian, E Weisbarth-Riedel, L Lepore, J Hoyer, I Foeldvari, E Ramos, P N Hawkins, K Leslie, G Krammer, R Preiss, A Widmer, J B Kuemmerle-Deschner. Canakinumab (ILARIS®) Provides Rapid Response and Sustained Remission in Children across Different Disease Severity Phenotypes of Cryopyrin Associated Periodic Syndrome (CAPS). ACR 2010. Arth Rheum 2010, 62.
I. Foeldvari, A. Wierk, D. Farge. When is autologous bone marrow transplantation indicated in juvenile systemic sclerosis. Results of a multinational survey of pediatric rheumatologist. 2 nd Systemic Sclerosis World Congress, 02.-04.2012, Madrid . Spain. Rheumatology 2012, Volume 51, Supplement 2; S1.4. ii2.
Seza Özen1, Jasmin Kuemmerle-Deschner2, Luca Cantarini3, Rolando Cimaz4, Pierre Quartier5, Ahmet Gül6, Isabelle Koné-Paut7, Steven Spalding8, Andrew Zeft8, Anna Simon9, Philip Hashkes10, Véronique Hentgen11, Tilmann Kallinich12, Sinisa Savic13, Ivan Foeldvari14, Joost Frenkel15, Uwe Machein16, Avi Livneh17, Helen J. Lachmann18. Patient Journey and Treatment Route to Use of First Biologic in Rare Autoinflammatory Diseases: An International Retrospective Chart Review. EULAR Annual Meeting Paris 2014.
Gerd Horneff*, Sophie Von Stackelberg, Ivan Foeldvari, J-P. Haas, Gerd Ganser, Kirsten Minden, Anton Hospach on behalf of the German and Austrian Collaborative BIKER study group. JADAS REMISSION AND MINIMAL DISEASE ACTIVITY UPON FIRST BIOLOGIC IN JIA. EULAR Annual Meeting Paris 2014.
Gerd Horneff, Ivan Foeldvari, Kirsten Minden, Klaus Tenbrock, Hans I. Huppertz, Ingrid Becker. ANALYSIS OF UVEITIS EVENTS IN THE BIOLOGICS IN PEDIATRIC RHEUMATOLOGY (BIKER)-REGISTRY. EULAR Annual Meeting Paris 2014.
N Ruperto,1 DJ Lovell,2 N Tzaribachev,3 G Vega-Cornejo,4 I Louw,5 A Berman,6 I Calvo,7 R Cuttica,8 G Horneff,9 F Avila-Zapata,10 J Anton,11 D Viola,12 I Foeldvari,13 V Keltsev,14 D Kingsbury,15 X Li,16 M Nys,17 R Wong,16 S Banerjee,16 A. Martini,18 HI Brunner2. Subcutaneous Abatacept in Patients with Polyarticular Juvenile Idiopathic Arthritis and Inadequate Response to Biologic or Non-biologic Disease-Modifying Antirheumatic Drugs: Pharmacokinetics, Efficacy and Safety. EULAR Annual Meeting London 2016.
I Foeldvari* 1 , N Ruperto1 , DJ Lovell2 , G Horneff1 , H-I Huppertz1 , P Quartier3 , G Simonini1 , M Bereswill4 , J Kalabic4 , AMartini1 , HI Brunner2 UVEITIS ASSOCIATED TO POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS (PJIA): DATA FROM STRIVE REGISTRY. PRES Meeting Genua 2016.
Ivan Foeldvari, Jordi Anton, Marc Friswell, Blanca Bica, Jaime Innocencio, Rebecca Nicolai, Nicola Helmus. Tocilizumab is a promising treatment option for therapy resistent juvenile localised scleroderma patients. Annual PRES meeting, Athens 2017.
I. Foeldvari 1, J. Klotsche2, O. Kasapcopur3, A. Adrovic3, V. Stanevicha3, K. Torok3, T. Terreri3, E. Alexeeva3, M. Katsikas3, V. Smith3, F. Sztajnbok3, T. Avcin3, R. Cimaz3, J. Anton3, M. Kostik3, T. Lehman3, W.-A. Sifuentes-Giraldo3, S. Appenzeller3, M. Janarthanan3, M. Moll3, D. Nemcova3, M.J. Santos3, C. Battagliotti3, L. Berntson3, J. Brunner3, D. Eleftheriou3, L. Harel3, T. Kallinich3, K. Minden2, S. Nielsen3, Y Uziel3, A. Stevens3, C.Pilkington3, N. Helmus1. Are patients with overlap features different from patients without? Results from the juvenile systemic scleroderma cohort www.juvenile-scleroderma.com. American College of Rheumatology Meeting 2017, Nov 08. San Diego, USA.
I. Foeldvari : Regarding the possible association of juvenile rheumatoid arthritis, Crohn’s disease and Turner’s syndrome. Letter to the editor. Clin Exp Rheumatol 1997; 15: 120.
I. Foeldvari: Progressive linear scleroderma and morphea in a child. Insights in Pediatrics. J Pediatrics 1988;133:308.
I. Foeldvari: Results of the multinational survey regarding feasibility-study for a therapeutic trial in juvenile systemic sclerosis. Letter. Clinical and Experimental Rheumatology 2000,18: 424.
I. Foeldvari : Do we need a pediatric rheumatologist? – The Hamburg Experience. Letter to the editor. Arth Rheumatism 1999,42:396.
I. Foeldvari: Anti-keratin antibodies in patients with JIA. Letter. Clin Exp Rheumatol 2001;19:762.
I. Foeldvari: A selective COX-2 inhibitor, meloxicam, as treatment option in patients with juvenile idiopathic arthritis and gastrointestinal side effects from naproxen. Letter. Clinical Exp Rheumatol 2002,20:874.
I. Foeldvari, T. Schneider: Acute, non-obstructive, sterile cholecystitis associated with Etanercept and Remicade for the treatmetn of juvenile polyarticular rheumatoid arthritis. Annals of Rheum Dis 2003, 62: 908-909.
I.Foeldvari, Y.Kimura, J.C.Jacobs: Congenital complement deficiency in childhood lupus: 17% require little or no treatment. Arthritis Rheum 1990; 33:S144, D63.
S. Lederman, M.J.Yellin, J.A.DeMartino, B.L. Daugherty, I. Foeldvari, A.M.C. Cleary, G.E. Mark and L. Chess: Regulation of T-cell functions by the CD4 molecule: Analysis of CD4- leukemic mutant before and after stable expression of CD4 cDNA. FASEB (AAI).61551:1991.
S. Lederman, J.A. DeMartino, B.L. Daugherty, M.J. Yellin, I. Foeldvari, A.M. Cleary, G.E. Mark and L. Chess. Molecular functional characterisation of a common African allele of the CD4 molecule. Clin Research. Seattle 1991. N37-0007.
S. Lederman, M.J. Yellin, J.A. DeMartino, B.L. Daughery, I. Foeldvari, A.M. Cleary, G. Mark and L. Chess: Mechanism of inducing B cell differentiation by a CD4-Jurkat clone: Surface features other than the lack of CD4 account for its constitutive ability to induce B cell activation. Clin Research. Seattle 1991. A36-0013.
Y.Kimura, I. Foeldvari, J.C. Jacobs: Azathioprine is a valuable agent in the treatment of pediatric lupus nephritis. Pediatric Research 1991; 29 (#4, Pt.2): 345A.
Y. Kimura, I. Foeldvari, J.C. Jacobs: Azathioprine is a valuable agent in the treatment of pediatric lupus nephritis. Lupus 1992; 1: S167.
I. Foeldvari: Prevalence of antiphospholipid antibodies in pediatric rheumatologic patients. Arthritis Rheum 1992; 35:S95, A162.
I. Foeldvari: The whole spectrum of expression of antiphospholipid antibodies in a family of 5. Arthritis Rheum 1992; 35: S356.
I. Foeldvari, C. Loeliger: Is there a HLA linkage with antiphospholipid antibodies in juvenile rheumatoid oligoarthritis? 1st European Conference on Pediatric Autoimmune and Rheumatic diseases (1993). Abstract book, GN4.
I. Foeldvari, T. Lehman: Is Methotrexate a new perspective in the treatment of Juvenile Progressive Systemic Scleroderma? 57th Annual Scientific Meeting of the American College of Rheumatology. Arthritis Rheum 1993; 36: (Suppl.) S218.
I. Foeldvari, C. Loeliger: Are Antiphospholipid Antibodies in JRA inherited? 57th Annual Scientific Meeting of the American College of Rheumatology. Arthritis Rheum 1993; 36: (Suppl.) S173.
I. Foeldvari, T. Lehman: Ist Methotrexat eine neue Perspektive in der Behandlung Juveniler Systemischer Progressiver Sklerodermie? Zeitschrift für Rheumatologie, 1993; 52:58K.
I. Foeldvari, R. Klein: Increased frequency of antikeratin antibodies in subset of children with oligoarticulare onset JRA who are positive for antiphospholipid antibodies. 2nd European Conference on Pediatric Autoimmmune and Rheumatic Diseases, Pavia, Italy, Clinical and Experimental Rheumatology 1994;12/S-10:121.
I. Foeldvari, R.E. Petty: Antibodies to human endothelial cells and cardiolipin in children with juvenile rheumatoid arthritis. 23rd Western Regional ACR Meeting (3/1995). Arthritis Rheum 1995; 38, No. 6 (Suppl) R9: Abstract 14.
I. Foeldvari, M. Zhavania, N. Birdi, P.B. Dent, R. Elborgh, F. Falcini, R. Häfner, R. Joos, A.M. Prieur, K. Rostropowicz-Denisiewicz, A. Savolainen, A. Siamopoulou-Mayridou, F. Zulian, R.E. Petty: Outcome of progressive systemic sclerosis (PSS) in 94 children: Results of a multi-national questionnaire. 59th National Meeting of the American College of Rheumatology; Art. Rheum 1995; 38 (Suppl): 1105.
I Foeldvari, M. Zhavania, N. Birdi, P.B. Dent, R. Elborgh, F. Falcini, H. Girschick, R. Häfner, R. Joos, W. Kuis, P. Pelkonen, A.M. Prieur, K. Rostropowicz-Denisiewicz, A. Savolainen, A. Siamopoulou-Mayridou, F. Zulian, R.E. Petty: Progressive systemic sclerosis (PSS) in 105 children showed a favourable outcome: Results of a multi-national questionnaire. 4th European Conference on Pediatric Rheumatology; Clinical Experimental Rheumatology 1996; 14: 465, A-74.
I. Foeldvari, R.E. Petty: Antibodies to human endothelial cells (aECA) and cardiolipin (aCL) in children with juvenile rheumatoid arthritis. 4th European Congress on Pediatric Rheumatology, Clin Exp Rheum 1996; 14: 459, A-42.
I. Foeldvari, M. Zhavania, N. Birdi, S.H.F. de Oliveira, P.B. Dent, R. Elborgh, F. Falcini, J.P. Garrahan, H. Girschick, R. Häfner, R. Joos, W. Kuis, P. Pelkonen, A.M. Prieur, K. Rostropowicz-Denisiewicz, A. Savolainen, A. Siamopoulou-Mayridou, F. Zulian, R.E. Petty. Progressive systemic sclerosis (PSS) in 119 children showed a favourable outcome: Results of a multi-national questionnaire. 5th European Conference on Pediatric Rheumatology, Garmisch-Partenkirchen. Rev.Rheum. (Engl.Ed.) 1997; 64: 228: F 10.
I. Foeldvari, M. Zhavania, N. Birdi, S.H.F. de Oliveira, P.B. Dent, R. Elborgh, F. Falcini, J.P. Garrahan, H. Girschick, R. Häfner, R. Joos, W. Kuis, P. Pelkonen, A.M. Prieur, K. Rostropowicz-Denisiewicz, A. Savolainen, A. Siamopoulou-Mayridou, F. Zulian, R.E. Petty. Progressive systemic sclerosis (PSS) in 120 children showed a favourable outcome: Results of a multi-national questionnaire. 61st National Meeting of the American College of Rheumatology, Washington, USA 11/97. Arthritis Rheumatism 1997, 40 (Suppl) Abstract 426.
I. Foeldvari, M. Zhavania, N. Birdi, R.J. Cuttica, S.H.F. de Oliveira, P.B. Dent, R. Elborgh, F. Falcini, G. Ganser, J.P. Garrahan, H. Girschick, R. Häfner, R. Joos, W. Kuis, P. Pelkonen, A.M. Prieur, K. Rostropowicz-Denisiewicz, R. Russo, A. Savolainen, A Siamopoulou-Mayridou, F. Zulian, R.E. Petty: Results of the multinational survey regarding outcome and clinical practice in juvenile systemic sclerosis: Summary of the data of 135 patients. 62nd Annual Congress of the American College of Rheumatology, 11/98 San Diego,USA. Arthritis Rheumatism 1998, 41 (Suppl) Abstract 1403.
I. Foeldvari, M. Birdi: Validation of the proposed Durban classification criteria for juvenile idiopathic arthritis in the patient population of the pediatric rheumatology Clinic in Hamburg, Germany. VI. European Paediatric Rheumatology Congress, 1999 Glasgow, UK. Annals of the Rheumatic Diseases 1999; Supplement XIV EULAR Congress: 322 (A 1344).
I Foeldvari, R. Burgos-Vargas; R. Linke: Preliminary results of a phase I/II study of meloxicam oral suspension in juvenile rheumatoid arthritis indicate high clinical response. 6th European Paediatric Rheumatology Congress, 1999 Glasgow, UK. Annals of the Rheumatic Diseases 1999; Supplement XIV EULAR Congress: 342 (A 1386).
B. Finckh, I. Foeldvari, D. Hülsebus, M. Meerwald, A. Kohlschütter. Changes of the pro/antioxidant balance in different subsets of juvenile idiopathic arthritis. 63rd Annual Congress of the American College of Rheumatology, Boston, USA, 1999. Arthritis Rheumatism 1999, 42 (Suppl) Abstract 665.
B. Finckh, I. Foeldvari, D. Huelsebus, M. Mehrwald, A. Kohlschütter: Differences in antioxidative status and free radical damage in juvenile idiopathic arthritis (JIA). 6th Annual Meeting of the Oxygen Society, New Orleans, USA, 1999. Free Radical Biol Med 1999, 27: S 121.
I. Foeldvari, R. Burgos-Vargas, A. Thon: 70% of the patients are responders after 12 weeks in the phase I/II study of meloxicam suspension in juvenile rheumatoid arthritis. Annual European Congress on Rheumatology- EULAR 2000, Nice, France. Annals of the Rheumatic Diseases 2000, 59 (Supppl 1): 252, POS-824.
I Foeldvari, C. Grave: Do we need a pediatric rheumatologist? – The Hamburg experience. Park City IV. Pediatric Rheumatology into the next century. Organised by the American Academy of Pediatrics. J Rheumatol 2000, 27 (Suppl 58): 102.
I. Foeldvari, A. Thon, R. Burgos-Vargas: 70% der Patienten mit juveniler rheumatoider Arthritis sprachen nach 12 Wochen auf eine Therapie mit Meloxicam-Suspension im Rahmen einer Phase I/II Studie an. Zeitschrift für Rheumatologie 2000, 59 (Suppl 3): 49 , P 60.
Ruperto, Murray, Bae, Prieur, Balogh, De Innocencia, Duarte, Foeldvari et. al. Part II. A generic instrument: the Child Health Questionnaire (CHQ). Ann Rheum Dis 2000; 59: 726 (A 4.20).
I. Foeldvari, R. Burgos-Vargas, A. Thon, D. Tuerck: Pharmacokinetics and clinical outcome of Meloxicam in juvenile rheumatoid arthritis. Ann Rheum Dis 2000; 59: 745 (A 11.26).
B. Finckh, I. Foeldvari, M. Mehrwald, D. Huelsebus, A. Koehlschuetter: Decrease of inflammatory disease activity parallels decrease of oxidative stress in juvenile idiopathic arthritis. Arth Rheum 2000,43 Suppl: S 357, A 1743.
I. Foeldvari, R. Burgos-Vargas, A. Thon: Long-term efficiacy and safety of meloxicam in juvenile rheumatoid arthritis. Arth Rheum 2000,43 Suppl: S 121 A 326.
K. Meyer, I. Foeldvari, L. Huck, S. Haubrich, B. Kahl-Nieke: Dentofacial morphology and temporomandibulare (TMJ) aspects in children with juvenile idiopathic arthritis. Arth Rheum 2000,43 Suppl: S 120, A: 321.
Machado, Ruperto, Murray, Bae, Prieur, Balogh, de Inocencia, Duarte, Foeldvari et al.: Inquerito internacional em 29 paises sobre qualidade de vida relacionada a saude em artrites idiopathicas juvenis: Parte II por meio de um instrumento generico – CHQ. Revista Brasileira de Rheumatologia 2000, 40 Suppl 1: S27, A TL-020.
I. Foeldvari: A selective COX-2 inhibitor, meloxicam (MX), as an effective alternative for treatment of patients with juvenile idiopathic arthritis. Ann Rheum Dis 2001, 60 Suppl 11: ii44 P 153.
I. Foeldvari: Results of leflunomide therapy in patients with juvenile idiopathic arthritis (JIA): a pilot noncontrolled therapeutic intervention. Ann Rheum Dis 2002, 61 Suppl 1: 235 – FRI 0273.
T. Schneider, E. Krüger, I. Foeldvari: Akute nicht obstruktive Cholecystitis – eine bisher bei Kindern nicht beschriebene Nebenwirkung von Enbrel (Etanercept) ?! Monatsschrift der Kinderheilkunde 2002, 150; 389.
G. Horneff, T. Biedermann, I. Foeldvari et al: The German etanercept registry for treatment of juvenile idiopathic arthritis. Arth Rheumatism 2002, 46 (Suppl) S482 , A 1279.
I. Foeldvari, A. Wierk.: Ergebnisse der Leflunomide (LEF) – Therapie bei Patienten mit juveniler idiopathischer Arthritis (JIA). 12. Jahrestagung der Arbeitsgemeinschaft für Kinder- und Jugendrheumatologie. Aktuelle Rheumatologie 2002, 27 : 277 (39).
N. Ruperto, N. Kuzmina, E. pachanov, Y. Shachbazian, A.M. Prieur, V. Artamonova, R. Joss, F. Zulian, R. Schwartz, A. Buoncompagni, W. Emminger, I. Foeldvari, F. Falcini, E. Baildam, A. Martini. A randomized trial of two dose regimen of meloxicam compared to naproxen oral suspension in juvenile idiopathic arthritis. Pediatric Rheumatology Online Journal 2003, 1 (Vol 3): Abstract 44.
I Foeldvari, A. Wierk. Vioxx? as an effective alternative for treatment of patients with juvenile idiopathic arthritis with side effects under other nonsteroidal drugs. Results of a therapeutic observation. Pediatric Rheumatology Online Journal 2003, 1 (Vol 3): Abstract 43.
I. Foeldvari, A. Wierk. Steroid induced osteoporosis in children with rheumatic diseases. Results of a pilot study. Pediatric Rheumatology Online Journal 2003, 1 (Vol 5): Abstract 142.
N. Ruperto, N. Kuzmina, E. Pachanov, Y. Shachbazian, R. Mouy, V. Artamonova, R.Joos, F. Zulian, R. Schwarz, A. Buoncompagni, W. Emminger, I.Foeldvari et al. A randomized trial of two dose regimen of meloxicam compared to naproxen oral suspension in juvenile idiopathic arthritis. Clinical Experimental Rheumatology 2003, 21: 542.
I. Foeldvari, A. Wierk. Results of calcaneal ultrasound measurement to assess steroid induced osteoporosis. Clinical Experimental Rheumatology 2003, 21: 556.
G. Horneff, H. Schmeling, I. Foeldvari et al: Drug survival and reasons for discontinuation of etanercept therapy in juvenile idiopathic arthritis. EULAR 2004 Berlin. Ann Rheum Dis 2004, 61 ( Suppl1): 383- FRI0468.
I. Foeldvari, A. Wierk. Results of leflunomide (LEF) therapy in patients with juvenile idiopathic arthriris(JIA): a pilot noncontrolled therapeutic intervention. Clin Expr Rheumatol 2004, 22: 524.
I. Foeldvari, A. Wierk. Healthy children have a significantly increased skin score asessed with the modified Rodnan Skin Score. ACR 2004. Artthritis Rheum 2004, 50 ( Suppl): S 419, A 1045.
G. Horneff, H. Schmeling, D. Moebius, I. Foeldvari. Efficacy of etanercept in active refractory juvenile spondyloarthropathy. Prospective open study of 40 patients. ACR 2004. Artthritis Rheum 2004, 50 ( Suppl): S 91, A 74.
I. Foeldvar, A. Wierk. Characteristics of patients with temporomandibular joint involvement associated to juvenile idiopathic arthritis. 33% of the patients are asymptomatic despite signs of active arthritis in imaging studies. EULAR 2005 , Ann Rheum Dis 2005, 64 – Supplement III: 509- SAT 0317.
I. Foeldvari, J. Kümmerle-Deschner, G. Horneff. A. Oliviere, C. le Blanc, M. Fischbach, Stella Garay, M. Hendrickson, M.M. Katsikas, K. O´Neill, J.P. Whelan, A. Wierk, T. Saurenmann. Results of a multinational survey regarding the use of tumor necrosis factor alfa blocker in the treatment of juvenile idiopathic arthritis associated severe uveitis. EULAR 2005, Ann Rheum Dis 2005, 64 – Supplement III: 509- SAT 0315.
G. Martini, F. Vittadello, B.H. Athreya, T.A. Lehman, I. Foeldvari, R. Russo, A. Eberhard, R. Cuttica, A. Ravelii, S.F.K. De Oliveira, G. Susic, G.A. Lysina, D. Nemcova, S. Nielsen, F. Falcini, R. Sundel, H. Girschick, A.P. Lotito, S. Al-Mayouf, I. Orban, R. Ten Cate, F. Zulian. Mortality in juvenile systemic sclerosis (jSS): Daa from the Padua international database of 153 patients. XII. European Pediatric Rheumatology Congress, Versaille, Frankreich 2005. Clinical Exp Rheumatol 2005; 23 (Suppl 37): S-42.
I. Foeldvari, A. Wierk. Results of the multinational survey regarding the use of tumor necrosis factor alfa blocker in the treatment of juvenile idiopathic arthritis associated uveitis refractory to second line agent. XII. European Pediatric Rheumatology Congress, Versaille, Frankreich 2005. Clinical Exp Rheumatol 2005; 23 (Suppl 37): S-63.
G. Martini, F. Vittadello, B.H. Atheya, T. Lehman, I. Foeldvari, R. Russo, A. Eberhard, R. Cuttica, A. Ravelli, G. Susic, R. Sundel, F. Falcini, H. Girschick, AP. Lotito, S. Al-Mayouf, I. Orban, R. TenCate, F. Zulian for PRES. Mortality in juvenile systemic sclerosis : data from the Padua international database of 153 patients. 2005 Annual Scientific Meeting of the American College or Rheumatology, San Diego, Ca., USA. Arthritis Rheum 2005, 52 (Suppl): A 1412.
F. Zulian, P. Woo, B.H. Athreya, R.M. Laxer, T.A. Medsger, T.A. Lehman, M. Matucci-Cerinic, G. Martini, A. Ravelli, R. Russo, R. Cuttica, S.F.K. de Olivieri, C. Denton, I. Foeldvari, N. Ruperto. Preliminary classification criteria for systemic sclerosis in children. 2005 Annual Scientific Meeting of the American College or Rheumatology, San Diego, Ca., USA. Arthritis Rheum 2005, 52 (Suppl): A 1413.
I. Foeldvari, J. Kümmerl-Deschner, S. Nielson, G. espada, G. Horneff, B. Bica, A.N. Olivieri, C. leBlanc, M. Fischbach, S. Garay, M. Henrickson, M. Katsikas, K. O´Neill, P.J. Whelan, A. Wierk, T. Saurenmann. Tumor necrosis factor alfa blocke rare effective in the treatment of juvenile idiopathic arthritis associated uveitis refractory to second line agents: results of the multinational survey. 2005 Annual Scientific Meeting of the American College or Rheumatology, San Diego, Ca., USA. Arthritis Rheum 2005, 52 (Suppl): A 1416.
I. Foeldvari, A. Wierk, D. Endres, K. Grünberg. Splints are an effective treatment for flexion contractres of the knee associated to juvenile idiopathic arthritis. Ann Rheum Dis 2006, 65 Suppl II: 646- AB0442.
A. Wierk, I. Foeldvari: Befragung von Kindern und Jugendlichen über die Akzeptanz und Probleme bei der Verwendung von Methotrexat in der Kinder- und Jugendrheumatologie. Kinder- und Jugendmedizin 2006, 6: A 47, Abstract 31.
I. Foeldvari, J. Anton, J. Davidosn, G. Higgins, T. Lehman, C. len, R. Russo, F. Zulian: Entwicklung eines Minimal-Standards zur Evaluation von Patienten mit juveniler Systemischer Sklerodermie. Kinder- und Jugendmedizin 2006, 6: A 51, Abstract 51.
I. Foeldvari, I.S. Szer, L.S. Zemel, M. Liu-Dumaw, B.J. Bloom. Report if a 12 week study of celecoxib vs Naproxen in children with juvenile rheumatoid arthritis. Arthritis Rheum 2006,54 (Suppl): S 683, A 171.
F. Zulian, T Avcin, I. Foeldvari, G. Martini, F. Vitadello, C. Wouters. The juvenile scleroderma international (JUSI) database. An instrument for improving research and standard of care in a rare disease in childhood. THU0337, EULAR 2007, Barcelona.
N. Ruperto, D.J. Loevell, S. Goodamn, A. Reiff, L. Jung, K. Jarosova, C. Sandborg, I. Foeldvari, et al. Long-term efficacy and safety of adalimumab in children with juvenile rheumatoid arthritis (JRA): converting from body surfa e area dosing to fixed-dosing in the open-label extension (OLE) of a phase III. study. THU0196 EULAR 2007, Barcelona.
I. Foeldvari, S. Nielsen, J. Anton-Lopez, G. Reuter, L. Hoppenrijs, B. Fiebig et. al. Methotrexate is an effective treatment option for juvenile idiopathic arthritis assoiciated uveitis. SAT0393, EULAR 2007, Barcelona.
I. Foeldvari, A. Wierk. Leflunomide is an effective alternative in the treatment for patient with juvenile idiopathic arthritis. SAT0394, EULAR 2007, Barcelona.
I Foeldvari, S Nielsen, J Anton, G Reutter, L Hoppenrijs, B Fiebig, N Tzaribachew, J Walsh, A Wierk. Methotrexyte is an effective treatment option for juvenile idiopathic arthritis associated uveitis. Poster 28, page 130, Abstract book of the 14 th European Pediatric Rheumatology Congress, Istanbul, Turkey. 2007.
C Mallattia, G Filocarmo, I Foeldvari, H Michels, C Pruunsild, S Nielsen et al. Identification of 254 famileis with juvenile idiopathic arthritis affected sibpairs: results of the PRINTO survey. Poster 67, page 174, Abstract book of the 14 th European Pediatric Rheumatology Congress, Istanbul, Turkey. 2007.
N Ruperto, DJ Lowell, S Goodman, A Reiff, L Jung, K Jarosoa, I Foeldvari, J Rovensky, K Minden, R vehe, GH Horneff, M McIlraith, J Medich, A martini, EH Giannini. Long-term efficacy and safety of adalimumab in children with juvenile rheumatoid arthritis (JRA): converting from body surface dosing to fixed dosing. Poster 69, page 176, Abstract book of the 14 th European Pediatric Rheumatology Congress, Istanbul, Turkey. 2007.
I Foeldvari, A Wierk. Most patients have an atypical presentation for familiar Mediterranean fever. Poster 139, page 255, Abstract book of the 14 th European Pediatric Rheumatology Congress, Istanbul, Turkey. 2007.
F Zulian, T Avcinb, I Foeldvari, G Martini, F Vittadello, C Wouters. The juvenile scleroderma international (JUSI) database: an instument for improving research and standard of care in a rare disease in childhood. Poster 269, page 397, Abstract book of the 14 th European Pediatric Rheumatology Congress, Istanbul, Turkey. 2007.
I. Foeldvari, J Anton, J Chaitow, E Baildam, G Higggins, T Lehman, C len, A Reiff, R Russo, F Zulian. Development of a minimal standard for the evaluation of patients with juvenile systemic sclerosis in a prospective inception cohort. Poster 270, page 398, Abstract book of the 14 th European Pediatric Rheumatology Congress, Istanbul, Turkey. 2007.
I Foeldvari, A Tyndall, F. Zulian, U. Mueller-Ladner, L. Czirjak, O. Kowal-Bielecka, D. Farge Bancel, M Matucci-Cerinic for the EUSTAR group. Similar outcome and organ involvement pattern of patients with juvenile and young adult onset systemic sclerosis. Data from the Eular Database. ACR 2007, Boston. Arthritis Rheum 2007, 56 (Suppl): A 1, S 53.
I Foeldvari, G Ganser, J Roth, R Trauzeddel, D Moebius, A Thon, R Haefner, K Mathony, A Wierk, G Horneff fort he members of the German Etanercept Registry. Etanecept is an effective therapeutic option for children with juvenile idiopathic enthesitis related arthritis- Results from the German Etanercept Registry. ACR 2007, Boston. Arthritis Rheum 2007, 56 (Suppl): A 225, S 135.
D Lowell, N. Ruperto, S Goodman, A Reiff, L Jung, K Jarosova, C Sandborg, I Foeldvari et al. Adalimumab fort h treatment of patients with juvenile rheumatoid arthritis: Safety and efficacy after conversion from body surface area dosing to weight-based fixed dosing. ACR 2007, Boston. Arthritis Rheum 2007, 56 (Suppl): A895, S 373.
G Honeff, I Foeldvari, G Ganser, H Michels, H Girscick, RM Kuester, A Thon. Growth reconstitution in juvenile idiopathic arthritis (JIA) upon treatment with etanercept is related to clinical improvement and gender. ACR 2007, Boston. Arthritis Rheum 2007, 56 (Suppl): A 900, S 375.
O Kowal-Bielecka, R Landewe, J Avouac, S Chwiesko, I Miniati, L Czirjak, P Clements, C denton, D Farge, K Fliegelstone, I Foeldvari et al. EULAR/EUSTAR Recommendation for the treatment of systemic sclerosis. ACR 2007, Boston. Arthritis Rheum 2007, 56 (Suppl): A 30, S 64.
I. Foeldvari, J. Anton, K. Minden, S. Nielsen, R.K. Sauerenmann, V. Strand, A. Heiligenhaus. Proposal for outcome measures for juvenile idiopathic arthritis related uveitis – from the JIA-Uveitis- Outcome Working Group. EULAR 2009, Copenhagen, FRI 0448. Ann Rheum Dis , 2009, Suppl.
I. Foeldvari, T. Avcin, K. Minden, C. Len, J. Anton, J. Chaitow, E. Baildam, G. Higgins, T. Lehman, S. Maillard, A. Reiff, R. Russo, F. Zulian, A. Wierk. Report form the recruitement process fort he juvenile systemic sclerosis inceptions cohorte. www.juvenile-scleroderma.com. EULAR 2009 Copenhagen, Denmark. Ann Rheum Dis 2009, 68, Suppl.
I. Foeldvari, B. Bica, F. Dedeoglu, A. Wierk. Efficacy of Rituximab in RF Factor negative juvenile idiopathic arthritis. FRI 0450EULAR 2009 Copenhagen, Denmark. Ann Rheum Dis 2009, 68, Suppl.
A.F. Jansson, C. Sengler, J. Kümmerle-Deschner, B. Gruhn, B. Kranz, H. Lehmann, D. Kleinert, L. Pape, D. Möbius, J. Peitz, D. Föll, H.J. Girschick, I. Foeldvari, J.P. Haas, D. Haffner, V. Grote. B-cell depletion for autoinflammatory diseases in pediatric patients a retrospecitve study. THU 0390 EULAR 2009 Copenhagen, Denmark. Ann Rheum Dis 2009, 68, Suppl.
I. Foeldvari, N. Helmus, A. Wierk. Validation of the proposed tool in Germany for early referral of children and adolescent with signs and symptomes suggestive of chronic arhtropathy to paediatric rheumatology centres. FRI 0449 EULAR 2009 Copenhagen, Denmark. Ann Rheum Dis 2009, 68, Suppl.
Minden K, Niewerth M, Weber K, Zink , Seipelt E, Foeldvari I, Girschick H, Horneff G. Long-term outcome of patients with juvenile idiopathic arthritis (JIA) treated with Etanercept-results of the biologic register JuMBO. ACR 2010.
Dörte Huscher, Nicholas Roubinis, Jerome Avouac, Frank Behrens, Christopher P Denton, Daniel E Furst, Ivan Foeldvari, Marc Humbert, Otylia Kowal-Bielecka, Marco Matucci-Cerinic, Peter Nash, Christian F. Opitz, David Pittrow, Lewis J Rubin, James R Seibold, Marius M Hoeper, Mark F Morris, Simon A Teal, Oliver Distler on behalf of the EPOSS group. Validation of 6 minute walking distance in patients with pulmonary arterial hypertension associated with systemic sclerosis. ACR 2010.
Ivan Foeldvari, MD, Angela Wierk, RN, Claudie Len, Maria Martha Katsicas, Avcin Tadey, Till Kallinich, Isabelll Kone-Paut, Kirsten Minden, Luc Mouthon, Juergen Brunner, Yuoef Uziel. Update on the Juvenile Systemic Sclerosis Inception Cohort. www.juvenilescleroderma.com.
I Foeldvari, G.Himmelmann. Preliminary results for 6 min walk values in healthy German children. 2 nd Systemic Sclerosis World Congress, 02.-04.2012, Madrid . Spain. Rheumatology 2012, Volume 51, Supplement 2; PS217, ii96.
I. Foeldvari: A rare Lymphoma, Franklin Syndrome. International Meeting of Young Oncologists, Szeged, Hungary, April 1987.
J. Dippel, I. Foeldvari: Therapy of juvenile chronic arthritis with polyarticular onset in relation to the detection of hidden IgM-rheumatoid factor. International Symposium on Pediatric Rheumatology, Paris, France, 1989.
I. Foeldvari, F.J. Schulte: Familiar accumulation of C4 deficiency and antiphospholipid antibodies. 4th Prague International Paediatric Rheumatologic Symposium. Prague 1992.
I. Foeldvari, R.G. Kopelman, J.C. Jacobs: Does complement deficiency predispose early age of onset of SLE? 4th Prague International Paediatric Rheumatologic Symposium. Prague 1992.
I. Foeldvari, M. Bidde: Ergebnisse der Befragung der Eltern über ihren Weg zu der Sprechstunde bei der Erstvorstellung in der kinderrheumatologischen Ambulanz. Jahrestagung der Arbeitsgemeinschaft Kinder- und Jugendmedizin, Tübingen, Mai 2000.
I. Foeldvari: Results of the multinational survey regarding a therapeutic study in juvenile systemic sclerosis. 6th International workshop on scleroderma research, Keble College Oxford, UK, 8/2000.
L.Huck, K. Meyer, I. Foeldvari, B. Kahl-Nieke: Juvenile idiopathische Arthritis – Ein Fallbericht. Deutsche Gesellschaft für Kieferorthopädie, 74. Jahrestagung Friedrichshafen, 09/2001.
K.Meyer, L. Huck, I. Foledvari, B. Kahl-Nieke: das Kiefergelenk bei juveniler idiopathischer Arthritis – Klinische Befunde und Diagnose. Deutsche Gesellschaft für Kieferothopädie, 75. Jahrestagung, Hamburg. 09/2002.
I. Foeldvari, A. Wierk. Healthy children have a significantly increased skin score assessed with the modified Rodnan Skin Score. VIII. International Workshop on Scleroderma Research – 2004, Trinity College, Cambridge, UK.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.